| Literature DB >> 31261867 |
Shiv Shankhar Kaundun1, Elisabetta Marchegiani2, Sarah-Jane Hutchings2, Ken Baker3.
Abstract
Most methods developed for detecting known single nucleotide polymorphisms (SNP) and deletion-insertion polymorphisms (DIP) are dependent on sequence conservation around the SNP/DIP and are therefore not suitable for application to heterogeneous organisms. Here we describe a novel, versatile and simple PCR-RFLP procedure baptised 'derived Polymorphic Amplified Cleaved Sequence' (dPACS) for genotyping individual samples. The notable advantage of the method is that it employs a pair of primers that cover the entire fragment to be amplified except for one or few diagnostic bases around the SNP/DIP being investigated. As such, it provides greater opportunities to introduce mismatches in one or both of the 35-55 bp primers for creating a restriction site that unambiguously differentiates wild from mutant sequences following PCR-RFLP and horizontal MetaPhorTM gel electrophoresis. Selection of effective restriction enzymes and primers is aided by the newly developed dPACS 1.0 software. The highly transferable dPACS procedure is exemplified here with the positive detection (in up to 24 grass and broadleaf species tested) of wild type proline106 of 5-enolpyruvylshikimate-3-phosphate synthase and its serine, threonine and alanine variants that confer resistance to glyphosate, and serine264 and isoleucine2041 which are key target-site determinants for weed sensitivities to some photosystem II and acetyl-CoA carboxylase inhibiting herbicides, respectively.Entities:
Keywords: EPSPS; PCR-RFLP; SNP; acetyl-CoA carboxylase (ACCase); dPACS; genotyping; herbicide resistance; photosystem II
Mesh:
Substances:
Year: 2019 PMID: 31261867 PMCID: PMC6651057 DOI: 10.3390/ijms20133193
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Species and populations used to validate the three derived Polymorphic Amplified Cleaved Sequence’ (dPACS) assays and corresponding Sanger sequencing and dPACS results.
| Species | Population | Origin | dPACS and Sanger Sequencing Assays | Genotypic Frequencies as Revealed by Sequencing and dPACS Assays |
|---|---|---|---|---|
|
| ArD1 | USA | S264G | 100% mutant G264 |
| ArD2 | Switzerland | S264G | 100% wild S264 | |
| ArD3 | USA | S264G | 100% wild S264 | |
| ArD4 | Switzerland | S264G | 100% mutant G264 | |
| ArD5 | Switzerland | S264G | 100% wild S264 | |
| ArD6 | Switzerland | S264G | 100% mutant G264 | |
|
| LmD1 | UK | I2041N ACCase | 25%II2041, 50%IN2041, 25%NN2041 |
| LmD2 | UK | I2041N ACCase | 100% II2041 | |
| LmD3 | UK | I2041N ACCase | 100% II2041 | |
| LmD4 | UK | I2041N ACCase | 100% II2041 | |
| LmD5 | UK | I2041N ACCase | 100% NN2041 | |
| LmD6 | UK | I2041N ACCase | 12.5% II2041, 87.5% NN2041 | |
|
| EiD1 | Philippines | P106S/T/A EPSPS | 100% SS106 |
| EiD2 | Malaysia | P106S/T/A EPSPS | 100% SS106 | |
| EiD3 | Ecuador | P106S/T/A EPSPS | 100 % AA106 | |
| EiD4 | Malaysia | P106S/T/A EPSPS | 100 % PP106 | |
| EiD5 | Malaysia | P106S/T/A EPSPS | 50% PP106, 25% PS106, 25% SS106 | |
| EiD6 | Malaysia | P106S/T/A EPSPS | 25% PP106, 75% SS106 |
Figure 1Schematic representation of the dPACS assays developed in this study. The targeted diagnostic di-nucleotides on the wild and mutant DNA sequences are in bold. Forces mismatches on the primers are underlined.
Figure 2Typical dPACS profiles for wild S264 and mutant G264 psbA Amaranthus retroflexus individuals. Lane 1: 50 bp DNA ladder, lanes 2, 3, 4 PleI restricted wild S264 haplotype; lanes 5, 6 and 7 PleI unrestricted mutant G264 haplotype.
Genotypic frequencies of wild and mutant psbA, acetyl-CoA carboxylase (ACCase) and 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) alleles as determined by corresponding dPACS assays in 27 herbicide-resistant populations from six different species.
| Species | Population | Origin | dPACS Assay | Genotypic Frequencies |
|---|---|---|---|---|
|
| CaR1 | Poland | S264G | 100% G264 |
|
| SnR1 | Germany | S264G | 100% G264 |
| SnR2 | Unknown | S264G | 100% G264 | |
|
| SvR1 | USA | I2041N ACCase | 100% II2041 |
| SvR2 | USA | I2041N ACCase | 87.5% II2041, 12.5% IN2041 | |
| SvR3 | Canada | I2041N ACCase | 100% II2041 | |
| SvR4 | USA | I2041N ACCase | 100% II2041 | |
| SvR5 | Canada | I2041N ACCase | 100% II2041 | |
| SvR6 | USA | I2041N ACCase | 100% II2041 | |
|
| EiR1 | Malaysia | I2041N ACCase | 100% II2041 |
| EiR2 | Philippines | I2041N ACCase | 87.5% II2041, 12.5 % NN2041 | |
| E2R3 | Malaysia | I2041N ACCase | 87.5% II2041, 12.5 % NN2041 | |
| EiR4 | Ecuador | I2041N ACCase | 100% II2041 | |
| EiR5 | Malaysia | I2041N ACCase | 100% II2041 | |
| EiR6 | Malaysia | I2041N ACCase | 75% II2041, 12.5% IN2041, 12.5% NN2041 | |
|
| ApR1 | USA | P106S/T/A EPSPS | 100% PP106 |
| ApR2 | USA | P106S/T/A EPSPS | 100% PP106 | |
| ApR3 | USA | P106S/T/A EPSPS | 100% PP106 | |
| ApR4 | USA | P106S/T/A EPSPS | 100% PP106 | |
| ApR5 | USA | P106S/T/A EPSPS | 100% PP106 | |
| ApR6 | USA | P106S/T/A EPSPS | 100% PP106 | |
|
| DiR1 | Brazil | P106S/T/A EPSPS | 100% PS106 |
| DiR2 | Brazil | P106S/T/A EPSPS | 100% PS106 | |
| DiR3 | Brazil | P106S/T/A EPSPS | 100% PS106 | |
| DiR4 | Brazil | P106S/T/A EPSPS | 100% PT106 | |
| DiR5 | Brazil | P106S/T/A EPSPS | 100% PS106 | |
| DiR6 | Brazil | P106S/T/A EPSPS | 100% PS106 |
Figure 3Typical dPACS profiles for wild and I2041N mutant ACCase Lolium multiflorum individuals. Lane 1: 50 bp DNA ladder, lanes 2 and 3 homozygous wild II2041 EcoRI restricted PCR fragment; lanes 6 and 7 homozygous mutant NN2041 unrestricted PCR fragment; lanes 4 and 5 heterozygous IN2041 plants containing one each of the unrestricted and restricted fragment.
Figure 4Typical dPACS profiles for wild and P106X mutant EPSPS Eleusine indica individuals. Lane 1: 50 bp DNA ladder, lanes 2, 3 and 4 homozygous wild PP106, heterozygous mutant PS106 and homozygous mutant SS106 individuals respectively as revealed by discriminative enzyme XcmI; lanes 5, 6 and 7 homozygous wild PP106, heterozygous mutant PS106 and homozygous mutant SS106 individuals respectively as revealed by discriminative enzyme XmnI; lanes 8 and 9 homozygous wild PP106 and homozygous mutant AA106 individuals respectively as revealed by discriminative enzyme Cac8I.
Sequencing and dPACS primers employed and corresponding PCR products and restriction digests. The forced nucleotide mismatches on the primers are in bold and underlined.
| Primer ID | Primer Length (bp) | Primer Sequence 5’–3’ | Target Codon and Amino | PCR Product, Restriction Enzyme and Digest | |
|---|---|---|---|---|---|
| Sequencing primers | SeqFw- | 25 | AAGGAAGCTTTTCTGATGGTATGCC | 264 | 426 bp; codons 165–307 |
| SeqRv- | 25 | CTACAGATTGGTTGAAGTTGAAACC | |||
| SeqFw-ACCase- | 22 | TGGCAGAGCAAAACTTGGAGGG | 2041 ACCase | 468 bp; codons 1954–2110 | |
| SeqRv-ACCase- | 23 | CTGAACTTGATCTCAATCAACCC | |||
| SeqFw-EPSPS- | 22 | GGAACAACTGTGGTGGATAACC | 106 EPSPS | 492 or 498 bp; codons 39–171 | |
| SeqRv-EPSPS- | 20 | CTTGCCACCAGGTAGCCCTC | |||
| dPACS primers | Fw-PsbA- | 40 | TGCTTCATGGTTACTTTGGTCGATTGATCTTCCAATATGC | S264 | |
| Rv-PsbA- | 41 | AAGCAGCTAAGAAAAAGTGTAAAGAACGAGAGTTGTTGA | 83 bp undigested; 48/35 bp digested | ||
| Fw-ACCase- | 35 | GCTTCTCTGGTGGGCAAAGAGACCTTTTTGAAGGA | I2041 ACCase | ||
| Rv-ACCase- | 55 | GGCAGGCAGATTATATGTCCTAAGGTTCTCAACAATTGTTGATCCAGCCTGCAG | 92 bp undigested; 58/34 bp digested | ||
| Fw-EPSPS-E. indica | 40 | GGTGCAGCTCTTCTTGGGGAATGCTGGAACTG | P106 EPSPS | ||
| Fw-EPSPS- | 40 | AGTTGCATTTCCTCCAGCAGCAGTTAC | 82 bp undigested; 47/35 bp digested | ||
| Rv-EPSPS- | 40 | GGTGCAGCTCTTCTTGGGGAATGCTGGAACTG | S106 EPSPS | ||
| Rv-EPSPS- | 40 | AGTTGCATTTCCTCCAGCAGCAGTTAC | 82 bp undigested; 45/37 bp digested | ||
| Fw-EPSPS- | 40 | GGTGCAGCTCTTCTTGGGGAATGCTGGAACTG | T106 EPSPS | ||
| Rv-EPSPS- | 40 | AGTTGCATTTCCTCCAGCAGCAGTTAC | 82 bp undigested; 42/40 bp digested | ||
| Fw-EPSPS- | 40 | GGTGCAGCTCTTCTTGGGGAATGCTGGAACTG | A106 EPSPS | ||
| Rv-EPSPS- | 40 | AGTTGCATTTCCTCCAGCAGCAGTTAC | 82 bp undigested; 43/39 bp digested | ||
Figure 5Typical dPACS profiles for wild and P106X mutant EPSPS Digitaria insularis individuals. Lane 1: 50 bp DNA ladder, lanes 2, 3 and 4 homozygous wild PP106, heterozygous mutant PS106 and heterozygous mutant PT106 individuals respectively as revealed by discriminative enzyme XcmI; lanes 5, 6 heterozygous mutant PT106 and heterozygous mutant PS106 individuals respectively as revealed by discriminative enzyme XmnI; lanes 7 and 8 heterozygous mutant PT106 and heterozygous mutant PS106 individuals respectively as revealed by discriminative enzyme RsaI.